Riskpilot← Back to searchSign inGet full accessMOLARUM AB
ABActiveOrg 5565495503Grev Turegatan 75Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19970 employees
Revenue 2025
SEK 101K
-13% vs 2024
EBITDA margin
-88.5%
-51% vs 2024
Equity ratio
20.1%
Financial strength
Net profit 2025
SEK 8K
+1550% vs 2024
| Revenue | SEK 101K | -13% |
| EBITDA | SEK -90K | -51% |
| Net profit | SEK 8K | +1550% |
| Total assets | SEK 662K | -1% |
| Equity | SEK 133K | +6% |
| Employees | 0 | — |
Legal name
MOLARUM AB
Org number
5565495503
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28 november 1997
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva import och handel med medicintekniska produkter, antikt och kuriosa samt vin, yttre trädgårds- och fastighetsskötsel samt därmed förenlig verksamhet.
Address
Grev Turegatan 75
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 206 | 123 | 93 | 117 | 101 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −481 | −1 348 | −124 | −59 | −90 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −481 | −1 348 | −124 | −59 | −90 |
| Net financials | — | — | −0 | 0 | 0 |
| Profit before tax | 0 | 2 | 1 | 1 | 11 |
| Tax | −0 | −0 | −0 | −0 | −3 |
| Net profit | 0 | 2 | 1 | 0 | 8 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 891 | 734 | 719 | 671 | 662 |
| Equity | 121 | 123 | 124 | 125 | 133 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 770 | 611 | 594 | 546 | 529 |
| Total debt | 1 770 | 611 | 594 | 546 | 529 |
EBITDA margin
-88.5%
This company
15.8%
Market median
-660% vs market
20212025
Equity ratio
20.1%
This company
38.2%
Market median
-47% vs market
20212025
Return on equity
6.0%
This company
18.4%
Market median
-67% vs market
20212025
Net profit margin
7.9%
This company
8.1%
Market median
-2% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
3.98×
This company
0.62×
Market median
-542% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Qvarner & Skoglund Aktiebolag
MOLARUM AB Board members of MOLARUM AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Olof Åkesson Qvarner | Deputy Board Member | 0 companies |
| Curt Åke Vincent Skoglund | Board of Directors | 0 companies |